Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19
Abstract Background Acute kidney injury (AKI) occurs among patients with coronavirus disease-19 (COVID-19) and has also been indicated to be associated with in-hospital mortality. Remdesivir has been authorized for the treatment of COVID-19. We conducted a systematic review to evaluate the incidence...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-02-01
|
| Series: | BMC Nephrology |
| Online Access: | https://doi.org/10.1186/s12882-021-02244-x |